About the journal
Biomarker Research is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,190 EUR. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BMC
- ISSN
- 2050-7771
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,190 EUR
- Articles in DOAJ
- 892
- Declared review time
- 10 weeks
- Declared peer-review model
- peer_review
- Official website
- https://biomarkerres.biomedcentral.com/
Index listings
- DOAJ · 2014-12-02
- PUBMED · 2013-01-16
- Indexing
- DOAJ · PUBMED
- APC
- 3,190 EUR
- Declared review time (DOAJ)
- 10 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
892
Most recent article
last month
Average review time (journal-declared via DOAJ)
10weeks
Works in OpenAlex
991
Last recorded publication year
2026
h-index
87
i10-index
612
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2014-12-02
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 12%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101607860
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- CAR-T cell therapy research
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
Show all subjects (50)
- RNA modifications and cancer
- RNA modifications and cancer
- Immune cells in cancer
- Immune cells in cancer
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Immune Cell Function and Interaction
- Lymphoma Diagnosis and Treatment
- Immune Cell Function and Interaction
- Cancer Genomics and Diagnostics
- Lymphoma Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Immunotherapy and Immune Responses
- Ferroptosis and cancer prognosis
- Immunotherapy and Immune Responses
- Ferroptosis and cancer prognosis
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Extracellular vesicles in disease
- Extracellular vesicles in disease
- Single-cell and spatial transcriptomics
- Single-cell and spatial transcriptomics
- Cancer Cells and Metastasis
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Circular RNAs in diseases
- Circular RNAs in diseases
- Cancer Cells and Metastasis
- Acute Lymphoblastic Leukemia research
- Cancer-related gene regulation
- Cancer-related gene regulation
- Acute Lymphoblastic Leukemia research
- Protein Degradation and Inhibitors
- Chronic Myeloid Leukemia Treatments
- Cancer, Hypoxia, and Metabolism
- Chronic Myeloid Leukemia Treatments
- Cancer, Hypoxia, and Metabolism
- Protein Degradation and Inhibitors
- Virus-based gene therapy research
- Virus-based gene therapy research
- Lung Cancer Treatments and Mutations
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Keywords (DOAJ)
- drug discovery
- personalised medicine
- disease diagnosis
- biomarkers
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ